Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 4, 2011, Pages 782-789

  Birbeck, Gretchen L ^a   Kvalsund, Michelle P ^b   Byers, Peter A ^a   Bradbury, Richard ^c   Mang'ombe, Charles ^d   Organek, Natalie ^a   Kaile, Trevor ^d   Sinyama, Alex M ^e   Sinyangwe, Sylvester S ^f   Malama, Kennedy ^g   Malama, Costantine ^h  

^a East Lansing   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Salvation Army   (United Kingdom)

^d Chikankata Health Services   (Zambia)

^e Nakambala Clinic   (Zambia)

^f Department of Pediatrics and Child Health ^*  (Zambia)

^g Provincial Health Office   (Zambia)

^h USAID   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ADULT; AGED; ANEMIA; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DEATH; DIVORCE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FOOD AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL HIV DEMENTIA SCALE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MORTALITY; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; POVERTY; PROSPECTIVE STUDY; RATING SCALE; RURAL POPULATION; SHONA SYMPTOM SCALE; SOCIAL STATUS; SOCIAL STIGMA; SOCIAL SUPPORT; SUICIDAL IDEATION; SURVIVAL; SYMPTOM; TOXIC EPIDERMAL NECROLYSIS; TRAVEL; TREATMENT OUTCOME; TREATMENT REFUSAL; ZAMBIA;

ADULT; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SOCIAL CLASS; ZAMBIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80053907776     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0187     Document Type: Article

References (40)

1. Lucas GM, Chaisson RE, Moore RD, 1999. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 131: 81-87. (Pubitemid 29340558)
2. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G, 2007. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 146: 564-573. (Pubitemid 351650537)
3. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS, 2004. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 20: 1053-1056. (Pubitemid 39392009)
4. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E, 2004. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 18 (Suppl 3): S27-S31. (Pubitemid 39037456)
5. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M, 2006. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
6. van Oosterhout JJ, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, de Baar MP, Schuurman R, Burger DM, Zijlstra EE, 2005. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health 10: 464-470.
7. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL, 2005. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 19: 1243-1249. (Pubitemid 41224892)
8. Marazzi MC, Bartolo M, Emberti Gialloreti L, Germano P, Guidotti G, Liotta G, Magnano San Lio M, Mancinelli S, Modolo MA, Narciso P, Perno CF, Scarcella P, Tintisona G, Palombi L, 2006. Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique. Health Educ Res 21: 34-42. (Pubitemid 43244080)
9. Uzochukwu BS, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI, 2009. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan 24: 189-196.
10. Orrell C, Bangsberg DR, Badri M, Wood R, 2003. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17: 1369-1375.
11. AIDS Patients Call for Holistic Approach. The Post.Lusaka.
12. IRIN, 2008. Living with HIV on an empty stomach. UN Office for the Coordination of Humanitarian Affairs.
13. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH, 2008. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr 47: 615-622. (Pubitemid 351442020)
14. Heckman TG, Somlai AM, Peters J, Walker J, Otto-Salaj L, Galdabini CA, Kelly JA, 1998. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care 10: 365-375. (Pubitemid 28297783)
15. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR, 2006. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 296: 679-690. (Pubitemid 44200639)
16. Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG, 2009. Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 19: 186-203.
17. Norman LR, Basso M, Kumar A, Malow R, 2009. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev 2: 143-156.
18. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J, 2010. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health 10: 111.
19. Birbeck G, Chomba E, Kvalsund M, Bradbury R, Mang'ombe C, Malama K, Kaile T, Byers P, Organek N, 2009. Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg 80: 669-674.
20. Birbeck G, Chomba E, Atadzhanov M, Mbewe E, Haworth A, 2007. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol 6: 39-44. (Pubitemid 44880258)
21. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E, 2005. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367-1374. (Pubitemid 41800672)
22. Kvalsund M, Haworth A, Murman D, Velie E, Birbeck G, 2009. Closing Gaos in ART access: HIV-D screening instruments for non-physician healthcare workers. Am J Trop Med Hyg 80: 1054-1059.
23. Jelsma J, Mhundwa K, De Weerdt W, De Cock P, Chimera J, Chivaura V, 2001. The reliability of the Shona version of the EQ-5D. Cent Afr J Med 47: 8-13.
24. Patel V, Simunyu E, Gwanzura F, Lewis G, Mann A, 1997. The Shona Symptom Questionnaire: the development of an indigenous measure of common mental disorders in Harare. Acta Psychiatr Scand 95: 469-475. (Pubitemid 27272196)
25. Kandiah PA, Atadzhanov M, Kvalsund MP, Birbeck GL, 2010. Evaluating the diagnostic capacity of a single-question neuropathy screen (SQNS) in HIV positive Zambian adults. J Neurol Neurosurg Psychiatry 81: 1380-1381.
26. Central Statistical Office, 2008. Living Conditions. Available at: http://www.zamstats.gov.zm/lcm.php. Accessed August 6, 2011.
27. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E, 2004. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18: 887-895. (Pubitemid 38553709)
28. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, 2008. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
29. Zachariah R, Harries K, Moses M, Manzi M, Line A, Mwagomba B, Harries AD, 2009. Very early mortality in patients starting antiretroviral treatment at primary health centers in rural Malawi. Trop Med Int Health 14: 713-721.
30. Maskew M, MacPhail P, Menezes C, Rubel D, 2007. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J 97: 853-857. (Pubitemid 47542654)
31. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD, 2007. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 85: 550-554. (Pubitemid 47041634)
32. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M, 2006. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793. (Pubitemid 44223102)
33. Mills EJ, Ford N, Mugyenyi P, 2009. Expanding HIV care in Africa: making men matter. Lancet 374: 275-276.
34. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R, 2009. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health 14: 722-731.
35. Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K, 2003. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med 26: 315-332. (Pubitemid 36890199)
36. Byron E, Gillespie S, Nangami M, 2008. Integrating nutrition security with treatment of people living with HIV: lessons from Kenya. Food Nutr Bull 29: 87-97.
37. Cettomai C, Kwasa J, Kendi C, Birbeck G, Price R, Bukusi E, Cohen C, Meyer A, 2010. Utility of quantitative sensory testing in characterizing HIV-associated peripheral neuropathy in western Kenya: pilot testing. Neurology 7 (Suppl2): A13.
38. Gross R, Yip B, Lo Re V 3rd, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JS, Hogg RS, 2006. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 194: 1108-1114. (Pubitemid 44547650)
39. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G, 2006. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 43: 78-84. (Pubitemid 44306492)
40. Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB, 2008. Pharmacy refill adherence compared with CD4 count changes for monitor ing HIV-infected adults on antiretroviral therapy. PLoS Med 5: e109.